CDBioSciences - VLPlant services

As is a leading global custom service provider, CD BioSciences dedicated to delivering highly customized and integrated solutions with the best quality to advance our customers` projects. CD BioSciences has a sophisticated VLPlant^TM platform and extensive experience dedicated to providing our customers with genetic fusion methods to modify virus-like particles (VLPs).

As a leading global provider of custom services, CD BioSciences has always been committed to providing highly customized and comprehensive solutions that advance our clients` projects with the best quality. Our experienced scientists are happy to meet each specific client requirement and provide the most appropriate solution. CD BioSciences has a sophisticated VLPlant platform and extensive experience in modifying VLPs by chemical conjugation to produce chimeric virus-like particles (cVLPs) for your development of vaccines, nanomaterials and diagnostics.

cVLPs are formed from VLPs and ligands through genetic fusion or chemical conjugation. As a leading global provider of custom services, CD BioSciences has advanced facilities and experienced scientists dedicated to cVLPs development services to help our customers develop vaccines, nanomaterials and diagnostic reagents.

Virus-like particles (VLPs) are nanoscale structures composed of assembled viral proteins that lack viral genetic material and are therefore not infectious. CD BioSciencesoffers VLPlant^TM, a plant-based recombinant expression system for constructing VLPs, which offers many advantages over traditional mammalian, yeast, insect, and bacterial expression systems.